Impact of Fascia Iliaca Block on Pain Outcomes and Opioid Consumption for Hip Fracture Patients-A Prospective, Randomized Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Hip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures)
- Sponsor
- Texas Tech University Health Sciences Center, El Paso
- Enrollment
- 97
- Locations
- 1
- Primary Endpoint
- Pain level
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
The study is a prospective randomized examining the impact of fascia iliaca block on perioperative pain control and post operative ambulation in patients with hip fractures.
Detailed Description
Regional anesthesia is an important element of multimodal pain control regimen for surgical patients. Recently, regional anesthesia using a fascia iliaca block (FIB) to help treat pain in patients who present with hip fractures has been gaining popularity and has been incorporated as part of a multi-modal pain control protocol in many centers. It is commonly offered in addition to oral and intravenous medications to help patients deal with pain in the perioperative period. The block is done by an anesthesiologist under anesthesia using ultrasound guidance. We propose a prospective, randomized study evaluating the efficacy of the FIB as an adjunct in the pre-operative or postoperative period for pain control as measured by visual analog scale (VAS) scores and morphine equivalent dosing (MED), as well as its efficacy in promoting patient participation in physical therapy postoperatively in patients who present with hip fractures. We hypothesize that those patients who receive FIBs will report lower VAS scores as well as decreased narcotic requirement at all time points; and have improved participation in therapy when measured by ambulation distance.
Investigators
Mai P. Nguyen
Assistant Professor
Texas Tech University Health Sciences Center, El Paso
Eligibility Criteria
Inclusion Criteria
- •Patients with femoral neck and intertrochanteric hip fractures
- •At least 18 years of age
- •Require operative management
Exclusion Criteria
- •Poly-trauma patients
- •Pathologic fractures
- •Patient who required revision procedures
- •Patients with chronic opioid use
- •Patients with a clinical status that precludes verbal pain assessment such as dementia, head injuries, and unwillingness to participate.
Outcomes
Primary Outcomes
Pain level
Time Frame: Three days after surgery
Visual analog scale scores and morphine equivalent dosing
Pain medication requirement
Time Frame: Three days after surgery
Morphine equivalent dosing
Secondary Outcomes
- Ambulation distance(Two days after surgery)